INTRODUCTION
============

*Clostridium difficile* is a spore-forming anaerobic bacterium that can cause antibiotic-associated diarrheal disease in humans. In the past decade, the incidence, complications and mortality of *C.difficile--*associated infection have increased dramatically owing to the emergence of new hypervirulent types ([@gks1448-B1]). Virulence of *C. difficile* has been linked to the production of two toxin molecules, Toxin A and Toxin B, which are encoded within the pathogenicity locus (PaLoc). These toxins cause intestinal damage and ultimately clinical disease ([@gks1448-B5]). Both toxins have the same enzymatic activity. On entering intestinal epithelial cells, they catalyze the transfer of glucose onto the Rho family of GTPases, leading to reorganization of the actin cytoskeleton, complete rounding of cells and destruction of the intestinal barrier function. This causes diarrhea and in some cases may lead to a severe inflammatory response and pseudomembranous colitis.

The mechanisms that regulate the levels of toxin synthesis are slowly being unraveled. Toxin genes, *tcdA* and *tcdB*, are located on the PaLoc together with two regulatory genes *tcdR* and *tcdC*, and *tcdE*, which encodes a holin-like protein that may facilitate the release of the toxins into the extracellular environment ([@gks1448-B6]). TcdR has been demonstrated to activate gene expression of both toxins as a specific RNA polymerase sigma factor belonging to the subgroup of extracytoplasmic function σ70-family of RNA polymerase sigma factors ([@gks1448-B7]). Members of this group include several sigma factors involved in positive regulation of potent toxins such as botulinum neurotoxin (BotR of *Clostridium botulinum*) and tetanus neurotoxin (TetR of *Clostridium tetani*) ([@gks1448-B8]). Toxin expression is also influenced by the nutritional status of the bacteria; a rapidly metabolizable carbon source such as glucose inhibits toxin expression ([@gks1448-B9]). In addition, general regulatory molecules such as CodY and CcpA are known to influence toxin synthesis ([@gks1448-B10],[@gks1448-B11]). In *C. difficile*, TcdR not only stimulates toxin gene transcription but also activates its own expression, suggesting a large overshoot in protein expression once activated ([@gks1448-B7]). A negatively acting mechanism, therefore, is required to put a limit on this system during unrestricted growth of *C. difficile*.

Activation of bacterial gene expression by specific sigma factors is often subject to control by specific antagonists, called anti-sigma factors ([@gks1448-B12]). Generally they sequester their cognate sigma factor, preventing it from interacting with the RNA polymerase (RNAP). Encoded within the PaLoc is TcdC, which has been postulated to act as an anti-sigma factor and negatively regulate toxin production. *TcdC* transcription pattern was reported to be inverse to *tcdR* and the toxins, as it is highly transcribed and expressed during the exponential growth phase, whereas its expression is strongly reduced, as the growth rate slows in stationary phase ([@gks1448-B13]). This inverse correlation suggested that TcdC interferes with toxin gene expression. However, more recent studies have shown that this inverse correlation cannot be confirmed using quantitative reverse transcriptase--polymerase chain reaction (RT-PCR) ([@gks1448-B14]). This suggests that TcdC may not be as important in toxin regulation as previously thought.

A direct inhibitory effect on transcription of *tcdC* has been shown *in vitro*. The TcdR--RNA-polymerase--DNA complex is destabilized by TcdC, preventing initiation of transcription. However, once a stable open complex is formed with the promoter, no inhibition by TcdC occurs ([@gks1448-B17]). The target of TcdC in (prevention of) complex formation is unclear; no interaction with the TcdR--RNAP complex was found nor does TcdC bind to dsDNA in the promoter, suggesting a potentially unique inhibitory mechanism of TcdC.

Recent *in vivo* studies on the importance of TcdC on toxin expression show contradictory results. *TcdC* complementation of strain M7404, a toxinogenic strain that lacks a functional *tcdC* gene, results in a reduced amount of produced toxin and an attenuated phenotype in hamsters ([@gks1448-B18]). In contrast, complementation of strain R20291, another strain that lacks a functional *tcdC* gene, with a functional *tcdC* gene did not alter the toxin titers ([@gks1448-B19]). In addition, knockout of *tcdC* in strain 630Δerm did not result in an increased level of toxins produced, nor did it result in increased toxin messenger RNA (mRNA) production ([@gks1448-B14]).

Because the suggested anti-sigma function of TcdC is not undisputed and because the mechanism by which TcdC is supposed to inhibit TcdR-mediated transcription is unknown, we aimed to further characterize the biochemical properties of TcdC. Through *in silico* analyses, we found that TcdC contains a predicted single-stranded (ss) nucleic acid binding fold \[oligonucleotide-binding fold (OB-fold)\]. In this article, we show for the first time through a combination of *in silico* analysis and biochemical experiments that TcdC can bind to nucleic acids.

MATERIALS AND METHODS
=====================

Construction of plasmids
------------------------

To construct his10-tagged TcdC expression plasmids, the sequence was amplified by PCR from *C. difficile* strain 630 genomic DNA, using specific primers, see [Table 1](#gks1448-T1){ref-type="table"}. The PCR products were digested with NdeI and XhoI or NdeI and BamHI and ligated into pET16b (Novagen) similarly digested with NdeI and XhoI/BamHI. This resulted in the construction of TcdC expression vectors containing a 10-His-tag at its N-terminus. Table 1.Primers used to generate bacterial expression constructs`Delta1-50 TcdC`` Forward primer, TATGCATATGGGATATGATACTGGTATTAC`` Reverse primer, TTTTCTCGAGTTAATTAATTTTCTCTACAGCTATCCC``Delta1-89 TcdC`` Forward primer, GTTCCATATGAAAGACGACGAAAAGAAAGCTATTG`` Reverse primer as for Delta1-50 TcdC``Delta1-130 TcdC`` Forward primer, TATGCATATGGGATATGATACTGGTATTAC`` Reverse primer as for Delta1-50 TcdC``Delta Delta1-89; Delta208-232 TcdC (90-207)`` Forward primer as for Delta1-89 TcdC`` Reverse primer, TACTGGATCCTTTAAGCACTTATACCTCTTATAG`

DNA-binding studies
-------------------

Probes used for band shift assays were obtained from Eurogentec (Maastricht, The Netherlands) end labeled with T4-polynucleotide kinase and ^32^P-γ-ATP and purified using Micro Bio-Spin Colums P-30 Tris RNase Free (Biorad) according to manufacturer's instructions.

Binding reactions were carried out for 60 min on ice in 20 μl binding buffer (20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid)--KOH pH 7.5, 50 mM NaCl, 40 mM KCl, 7% glycerol, 1 mM ethylenediaminetetraacetic acid, 0.1 mM dithiothreitol and 0.25 pmol probe (12.5 nM). Free DNA and protein--DNA complexes were separated on a 7% polyacrylamide gel (37.5:1) run in 0.5× Tris/Borate/EDTA. Dried gels were exposed to a Biorad phosphoimaging screen-K and scanned on a Typhoon 9410 from GE Healthcare.

The equilibrium dissociation constant (Kd) was calculated at half saturation Kd = Pt−Db (Db = DNA bound, 6 nM). The Pt (total protein concentration) was calculated using a deduced molecular mass of 18.8 kDa for the His10-TcdCΔ1-89 protein.

Single-stranded SELEX
---------------------

The random site used in the first selection round was 5′ AGTGCAGTGGATCCTGTCG-NNNNNNNNNNNNNN-AGGCGAATTCAGTCCAAGTG 3′, ^32^P-labelled at the 5′ end. Binding reactions were as described above with 10 or 100 ng purified TcdC Δ1-89. In the first selection round, 10 μl of 50% Cobalt^2+^-beads (Clontech) in binding buffer was added to the binding reaction and incubated for 30 min at 4°C under continuous rotation. Subsequently the beads were spun down (30 s at 100 g) and washed three times in 100 μl binding buffer. Bound random oligo was eluted in 20 μl binding buffer with 250 mM Imidazol and subsequent heating for 10 min at 95°C. Beads were spun down and supernatant collected. Five microliter of supernatant was amplified using 30 PCR cycles with primers, AGTCAGTGCAGTGGATCCTGTCG (forward) and CACTTGGACTGAATTCGCCTC (reverse). The resulting 53 bp PCR product was digested with N.BtsI nicking endonuclease (New England Biolabs) and labeled using ^32^p-γ-ATP. Digested and labeled probe was separated on a 12% polyacrylamide gel (19:1). Following exposure of the wet gel to radiographic film (Fujifilm, super RX), the highest band corresponding to the uncleaved top strand was cut out and eluted according to the QIAEX II Gel Extraction Kit for polyacrylamide Gels (Qiagen). Five microliters of the extracted probe was used in the next round of selection using bandshift assay. The Protein--DNA complexes were separated on a 7% polyacrylamide gel as described above. After exposure to film, the bound probe (shift) was cut out and eluted for an additional round of selection.

Quadruplex staining
-------------------

Specific staining of quadruplex-forming DNA was performed according to Yang *et al.* ([@gks1448-B20]). Briefly, polyacrylamide gels were incubated in 20 μM ETC (3,3′-di(3-sulfopropyl)-4,5,4′,5′-dibenzo-9-ethyl-thiacarbocyanine triethylammonium salt, C~39~H~47~N~3~O~6~S~4~, Organica Feinchemie GmbH Wolfen) in phosphate buffer saline for 30 min. Rinsed five times with water and then scanned in a Typhoon 9410 (GE Healthcare), excitation 532 nm and emission 610 nm.

Bioinformatics analysis
-----------------------

For all bioinformatic analyses, protein sequence Q189K7 (*C. difficile* strain 630) was used.

Predictions of coiled-coil helices were carried out using the Multicoil Scoring Form \[([@gks1448-B21]); <http://groups.csail.mit.edu/cb/multicoil/cgi-bin/multicoil.cgi>\]. All predictions were performed using standard settings.

All sequence alignments were performed by use of Clustal Omega---Multiple Sequence Alignment, available from EMBL-EBI European bioinformatics institute (<http://www.ebi.ac.uk/Tools/msa/clustalo/>; ([@gks1448-B22]).

Structural models of the TcdC-conserved C-terminal domain were generated by the automated I-TASSER (threading, assembly and refinement) simulation method; <http://zhanglab.ccmb.med.umich.edu/I-TASSER/> ([@gks1448-B23],[@gks1448-B24]). Predictions were done using the standard parameters.

As part of sequence homology detection, the protein alignment was analyzed using HHpred at the Max-Planck Institute for Developmental Biology \[<http://toolkit.tuebingen.mpg.de/hhpred>; ([@gks1448-B25])\]. Predictions were done using the following parameters: Selected, database pfamA_v26.0; Max. MSA Generation iterations, 0. Other parameters set at default.

Protein purification
--------------------

*Escherichia coli* (BL21) lysates (50 mM sodium phosphate buffer, pH 8.0, 5 mM beta-mercaptoethanol, 0.1% NP40, 300 mM NaCl) containing histidine-tagged proteins were loaded on a 1 ml Ni-NTA column (Qiagen). The column was washed with 20 ml wash buffer (50 mM sodium phosphate buffer pH 7.0, 300 mM NaCl, 5 mM mercaptoethanol, 5% glycerol, 20 mM Imidazol). The His-tagged proteins eluted at ∼200 mM imidazole when using a 25 ml linear gradient ranging from 20 to 250 mM imidazole. Peak fractions containing the His-tagged proteins were pooled and 200 μl loaded onto a superdex 75 gelfiltration column equilibrated and run in 50 mM sodium phosphate buffer pH 7.0, 150 mM NaCl, 5 mM mercaptoethanol, 5% glycerol. Protein concentrations were measured and peak fractions were used for DNA-binding studies.

RESULTS
=======

*In silico* analysis of TcdC
----------------------------

In many cases, sequence similarity allows the inference of protein function. At the primary amino acid (aa) sequence level, the C-terminal domain of TcdC (residues 130--232, conserved domain, [Figure 1](#gks1448-F1){ref-type="fig"}A) has sequence identity (conservation) to potential/putative protein homologues from both anaerobic and facultative aerobic members of the Firmicutes phylum (see [Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1448/-/DC1)). Though several TcdC homologues have been identified, none of them have been characterized biochemically in detail and therefore do not provide a clue to the TcdC mechanism of action. Figure 1.Domain organization of *C. difficile* TcdC. (**A**) Schematic presentation of TcdC with three predicted domains; Hyd = hydrophobic membrane anchor, Dim = dimerization domain and OB-fold = conserved C-terminal domain containing a predicted oligonucleotide-binding fold. Bottom, spatial structure of the TcdC--C-terminal domain (aa 90--232) predicted by the automated simulation method I-TASSER ([@gks1448-B23]) and represented with a ribbon diagram. N and C indicate amino-terminus and carboxy-terminus. (**B**) Limited proteolysis of TcdCΔ1-50 and TcdCΔ1-130. Histidine-tagged proteins were digested with chymotrypsin for 5, 30, 60 or 120 min, and the fragments were resolved by sodium dodecyl sulphate--polyacrylamide gel electrophoresis. Amino-terminal sequences were identified using an Edman degradation. Site of chymotrypsin cleavage (arrow 1) indicated in the primary aa sequence and TcdC predicted secondary structure elements. H = helix (red box), C = coil (blue line), S = sheet (pink arrow).

As the primary sequence gave no indication to its function, we used computational protein structure prediction for detecting remote homologous templates.

Structural models of the TcdC-conserved C-terminal domain were generated by the automated I-TASSER (threading, assembly and refinement) simulation method ([@gks1448-B23],[@gks1448-B24]). The best model ([Figure 1](#gks1448-F1){ref-type="fig"}A) was predicted to be composed of a five-stranded closed beta-barrel connected by large loops (C score = −0.9; C score is a confidence score for the predicted model. A C score \>−1.5 is used to select models of correct topology). Matching the best predicted model with proteins from the protein database revealed a nucleic acid binding OB-fold (oligonucleotide binding, IPR016027) containing domain in all the 10 top matches/best scoring templates (Topology Match (TM) = 0.8--0.7; TM-score \>0.5 indicates a model of correct match topology). The core of the OB-fold forms a surface to bind to ssDNA or RNA ([@gks1448-B26],[@gks1448-B27]). Variations in folds, loops and aa in the binding interface determine ligand and sequence specificity. Members of this OB-fold group include proteins critical for DNA replication protein (RPA), DNA recombination (RuvA), translation (transfer RNA synthetase anticodon binding protein) and telomere-end-binding proteins (hPot-1) ([@gks1448-B26],[@gks1448-B27]).

I-TASSER folding of the region preceding the conserved domain (aa 90--130) predicted a large helix ([Figure 1](#gks1448-F1){ref-type="fig"}A) containing many positively and negatively charged aa. Such a helix clearly can form a charged coiled-coil motif with another molecule, thereby forming an intertwined dimer as was predicted by Matamouros *et al.* ([@gks1448-B17]). The coiled-coil prediction was confirmed using the Multicoil Scoring Form ([@gks1448-B21]), which calculated a maximum coiled-coil probability of 0.861 of this region (data not shown).

In addition to the protein structure prediction, we used the TcdC conserved domain protein alignment ([Supplementary Figure S1](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1448/-/DC1)) for a highly sensitive profile-based search ([@gks1448-B25],[@gks1448-B28]). Using the TcdC-conserved domain, multiple-sequence alignment rather than a single sequence as a query increases sensitivity and allows for homology detection of protein families. Pairwise comparison of the TcdC profile with the PFAM database resulted in a hit with PF12869, tRNA_anti-like family containing the nucleic acid-binding OB-fold (E-value 1.3e-6, probability 98.3).

In summary, these *in silico* analyses clearly suggest that TcdC forms a dimeric ssDNA binding OB-protein fold.

Limited proteolysis suggests a folded structure of the TcdC-conserved domain
----------------------------------------------------------------------------

To confirm the predicted domains and borders of the nucleic acid binding OB-fold of TcdC, we cloned the *tcdC* gene including 10-histidine codons at the N-terminus into a bacterial expression vector. To produce soluble protein expression in *E. coli*, the first 50 aa, which contain the reported hydrophobic membrane anchor \[([@gks1448-B13]) and [Figure 1](#gks1448-F1){ref-type="fig"}A\] were removed. His-10--tagged TcdC was overexpressed in *E. coli* (BL21) and purified using a nickel affinity column (see 'Materials and Methods' section).

To investigate the local conformation of this TcdC protein, we used limited proteolytic digestion. Protease resistance is an indication of structured protein sequences, as folded structure is usually protected from proteolytic degradation. TcdCΔ1-50 was digested with chymotrypsin, which cleaves after aromatic aa. Despite the presence of 11 potential cleavage sites (W, Y, F), chymotrypsin digestion of TcdCΔ1-50 led to only one distinct fragment ([Figure 1](#gks1448-F1){ref-type="fig"}B). To identify this fragment, the proteolytic product was subjected to N-terminal sequencing using Edman degradation. The identified N-terminal sequence (KMKD) corresponds to residue 88 of TcdC directly adjacent to the large coiled-coil helix. When we tested TcdCΔ1-130 ([Figure 1](#gks1448-F1){ref-type="fig"}B), corresponding to the OB-fold domain, we observe hardly any cleavage.

Taken together, these studies provide strong support for a folded structure of the TcdC conserved domain, including the dimerization domain, resistant to proteolytic cleavage.

TcdC contains a dimerization domain
-----------------------------------

Consistent with the proteolytic protection assay and prediction of the coiled-coil dimerization helix, we constructed an expression vector containing the TcdC-conserved domain including this putative dimerization domain (TcdCaa90-232, here named TcdCΔ1-89). In addition, a construct without the dimerization domain (TcdCΔ1-130) was generated. Both proteins were subsequently purified using nickel--affinity chromatography and gel-filtration (see [Supplementary Figure S2](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1448/-/DC1)).

Besides extra purity, the latter column allows for separation by size and thus molecular weight estimation (see [Supplementary Figure S3](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1448/-/DC1)). Indeed the apparent molecular weight of TcdCΔ1-89 of 35 kDa, with a predicted molecular weight of 18 kDa, fits a dimeric protein. In contrast, TcdCΔ1-130, with a predicted molecular weight of 14 kDa and apparent molecular weight of 14 kDa, fits a monomeric protein. This confirms that the region between aa 90--130 contains a dimerization domain. Dimerization was confirmed using a cross linking with glutaraldehyde, which can form stable intersubunit covalent bonds (supplemental [figure 3](#gks1448-F3){ref-type="fig"}C). This experiment shows that TcdC Δ1-130 forms no visible dimers after crosslinking, while TcdC Δ1-89 forms dimers already at low concentration of glutaraldehyde, thereby confirming the gel-filtration experiments.

TcdC does not bind to *tcdA* promoter elements
----------------------------------------------

Based on existing evidence for the TcdC point of action, i.e. destabilizing open complex formation before transcription initiation ([@gks1448-B17]), we tested binding to (ss-)DNA corresponding to the region of the *tcdA* promoter that undergoes melting during transcription (opening of the double helix, resulting in exposed ssDNA) ([@gks1448-B29],[@gks1448-B30]). Using protein TcdC Δ1-89 in a mobility shift assay, we tested binding to the *tcdA* double-stranded (ds) promoter (−32 to +22 relative to transcription start), ss promoter top strand (non-template), ss promoter bottom strand (template), open promoter complex (region −10 to −6 or −13 to +4 open) as well as the *tcdA* mRNA gene transcript (+1 to +22) and the DNA--RNA hybrid (see [Table 2](#gks1448-T2){ref-type="table"}). Surprisingly, we found no DNA binding for any of these fragments (data not shown). Also partially ds/ss overhang (5′ and 3′) and forked templates of the promoter (see [Table 2](#gks1448-T2){ref-type="table"}) showed no binding. Finally, we tested a synthetic Holliday junction ([@gks1448-B31],[@gks1448-B32]), which can be found at replication origins and recombination junctions, but found no binding. Table 2.Primers used to test TcdC ss/ds DNA binding![](gks1448t2.jpg)

TcdC binding sites selected through SELEX
-----------------------------------------

Because of our unsuccessful attempt to find the TcdC DNA-binding site directly, we adapted a ssSELEX \[Systematic Evolution of Ligands by EXponential enrichment, ([@gks1448-B33])\], a procedure that allows extraction of oligomers with an optimal binding affinity from an initially random pool of oligonucleotides ([Supplementary Figure S4](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1448/-/DC1)). After site-selection and PCR amplification, ssDNA is recreated using (asymmetric-) nicking of the bottom strand of the amplified selected sites followed by denaturation. These sites are subsequently used in an additional selection round, thereby increasing the specificity of the selection procedure (see 'Materials and Methods' and [Figure 2](#gks1448-F2){ref-type="fig"}). Figure 2.Mobility shift assay of TcdC Δ1-89 selected binding sites. ssDNA selected at each round (see 'Materials and Methods') were used as probes in gel mobility analysis. The selection rounds are indicated. Shifted probes in round 2 and 3 were cut out and eluted as indicated and cloned after the last round.

Initial selection of his10-TcdCΔ1-89 bound fragments from the pool of ss-oligonucleotides, containing a stretch of 15 random nucleotides was performed through Cobalt^2+^-agarose beads pull down (round 1, [Figure 2](#gks1448-F2){ref-type="fig"}). Two additional selection rounds were carried out using separation of bound DNA fragments on a polyacrylamide gel (round 2 and 3, [Figure 2](#gks1448-F2){ref-type="fig"}).

During these selection rounds, we observed a higher molecular weight product (HMW) arise, which is bound and shifted by TcdCΔ1-89 ([Figure 2](#gks1448-F2){ref-type="fig"}). Each round showed a clear enrichment of the amount of HMW product being bound and shifted in the presence of TcdCΔ1-89. After three rounds of selection, the enriched sites were cloned and sequenced. [Table 3](#gks1448-T3){ref-type="table"} shows the individual sites selected by the TcdCΔ1-89 ssSELEX. Most of the sequences selected (17 of 18) contain a stretch of three Gs (highlighted bold) and two-third of the selected clones contains an A nucleotide preceding this G-stretch. Six out of 18 clones contain two stretches of three Gs. Table 3.Selected binding sites for the TcdCΔ1-89 protein in a ssSELEX![](gks1448t3.jpg)[^1]

Next, we selected two sites obtained from the ssSELEX. One clone with a single aGGG consensus site (clone \#2, [Table 3](#gks1448-T3){ref-type="table"}) and one with a double consensus site (clone \#5, [Table 3](#gks1448-T3){ref-type="table"}) and tested these individually on a polyacrylamide gel. As shown in [Figure 3](#gks1448-F3){ref-type="fig"}A, both clones form the HMW product also observed in the ssSELEX, although in different efficiencies (on average ∼90% of \#5 formed HMW product compared with ∼10% of clone \#2). When we tested TcdC binding, the HMW band was readily shifted, thereby confirming their efficient binding selection. In contrast to the HMW product, none of the ssDNA product was shifted ([Figure 3](#gks1448-F3){ref-type="fig"}A). Assuming a simple binding model, gel retardation experiments allow for a quick estimate of the protein equilibrium binding constants (Kd) at half saturation using the formula Kd = Pt−Db (the total protein and DNA concentrations at 50% binding). Quantification of the binding revealed a protein dissociation constant of ∼30 nM ([Figure 3](#gks1448-F3){ref-type="fig"}b). When we assume that TcdC binds as a dimer (see below), the Kd is ∼15 nM. Typically, affinity of OB-fold proteins range from 1 nM to 100 nM ([@gks1448-B34]). Figure 3.Binding characteristic of TcdC Δ1-89. (**A**) Binding to two selected clones (\#2 and \#5 corresponding to [Table 3](#gks1448-T3){ref-type="table"}) was tested using 100 ng of TcdCΔ1-89 in a bandshift assay (shift indicated protein--DNA complex). (**B**) Determination of the dissociation constant of TcdCΔ1-89 for \#5 HMW binding. Lanes 1--7 of the inset gel shows increasing concentrations of TcdCΔ1-89 3 ng, 6 ng, 12 ng, 25 ng, 50 ng and 100 ng. Band shift assays were performed as described under 'Material and Methods' section.

On titration of TcdC, at least three complexes can be observed, which suggest multiple binding sites on the quadruplex structure (QS) ([Figure 3](#gks1448-F3){ref-type="fig"}B), with the first shifted complex representing the highest affinity binding site. Alternatively, the dimeric protein might bind more than one QS (each monomer binding separate quadruplexes), thus forming larger complexes.

Characterization of the TcdC bound sequences
--------------------------------------------

To characterize the structure of the HMW product and demonstrate that the HMW complex is the result of intra- or intermolecular structures, we heated radiolabeled clone \#5 in the presence of formamide, thereby denaturing DNA duplexes and secondary structures. On heating, the HMW product shifts to a lower molecular weight ([Figure 4](#gks1448-F4){ref-type="fig"}A), suggesting that the DNA element is a multiplex forming secondary structures. The fact that this unusual HMW structure is likely to be a multiplex and contains stretches of GGGs suggested that it could form a so-called G-quadruplex, a four-stranded helical structure with four guanine bases from each strand forming hydrogen bonds (G-tetrads). Three (or more) guanine tetrads can stack on top of each other to form a G-quadruplex. We therefore tested the HMW product with ETC (C~39~H~47~N~3~O~6~S~4~), an extended aromatic cyanine dye that specifically recognizes stacked G-quadruplexes ([@gks1448-B20]). [Figure 4](#gks1448-F4){ref-type="fig"}B shows that ETC specifically stains the HMW product but not duplex and single-strand DNA (compare with [Figure 4](#gks1448-F4){ref-type="fig"}C), confirming that the selected element forms a G-quadruplex. Figure 4.Characterization of a TcdC-bound sequence element. (**A**) HMW is formed by intermolecular interactions, which are lost at 5 min 95°C in formamide. DNA was 5′-end labeled with ^32^Pγ-phosphate for visualization using storage phosphor screen autoradiography. (**B**) Recognition of HMW product by ETC: a quadruplex-specific stain (see 'Materials and Methods' section). (**C**) Loading control of gel-samples loaded in panel B. Each DNA was 5′-end labeled with ^32^Pγ-phosphate (see 'Materials and Methods' sections). (**D**) Point mutations affecting G-quadruplex formation. G-stretches and mutated positions are in bold underlined. Probes were ^32^P-labelled and separated on a 10% polyacrylamide gel. Quadruplex is indicated.

To further support the QS proposed for the \#5 sequence, we analyzed the HMW formation with a number of point mutations. We did not observe changes in the quadruplex HMWs when the T9 preceding the G-stretches was replaced with C ([Figure 4](#gks1448-F4){ref-type="fig"}D). However, mutations at positions 12, 15, 18 and 21 of the \#5 sequence resulted in significant alteration of migration on the gel, presumably due to a loss of QS. Especially when guanines involved in a G-tetrad formation, G12 and G15, were substituted with a C, the mutations completely abrogated the capacity of the sequence to fold into a G-quadruplex.

TcdC binds as a dimer
---------------------

Above we have shown that the dimerization coiled-coil helix forms a proteolytically protected structure together with the OB-fold. We were interested to determine if dimerization is required for efficient recognition and binding of the G-quadruplex. Therefore, electrophoretic mobility shift assay was carried out with TcdCΔ1-130, which behaves as a monomer (see above). [Figure 5](#gks1448-F5){ref-type="fig"} shows that no binding occurred with purified TcdCΔ1-130, indicating requirement of the TcdC dimerization domain for efficient binding. To exclude the possibility that the loss of binding by TcdCΔ1-130 is caused by direct binding of the coiled-coil domain to the quadruplex, we tested a TcdC protein, which does contain the dimerization helix (aa 90--130) but lacks the C-terminal part of the OB-fold, containing a loop forming part of the putative ssDNA-binding channel (aa 208--232). This protein, TcdC Δ1-89_Δ208-232, showed no binding to the QS (see [Figure 5](#gks1448-F5){ref-type="fig"}), confirming that the coiled-coil domain is not directly involved in quadruplex binding. Figure 5.TcdC dimerization domain is required for DNA binding. TcdC dimer (Δ1-89) or monomer (Δ1-130) was incubated with oligo \#5. Only the TcdC dimer was able to bind to the quadruplex DNA, as evidenced by the shifted DNA.

DISCUSSION
==========

TcdC has been described to act as a factor responsible for inhibition of transcription of the toxin genes. Here we describe that the conserved carboxy terminal domain of TcdC is predicted to form a coiled five-stranded beta-sheet capped by an alpha helix (see [Figure 1](#gks1448-F1){ref-type="fig"}A). This common fold has been described in different proteins, which bind oligonucleotides or oligosaccharides and thus named OB-fold ([@gks1448-B35]). Using ssSELEX, a method to determine the binding site of TcdC, we found that the optimal binding site forms a G-quadruplex.

G-quadruplexes are nucleic acid sequences rich in guanine and capable of constituting a four-stranded structure. These four-stranded structures are stabilized through hydrogen bonds between four guanine bases forming a square planar structure called a guanine tetrad ([@gks1448-B36]). Typically three guanine tetrads can stack on top of each other to form a G-quadruplex. Quadruplexes can be formed in DNA as well as RNA and can be diverse, as GGG interactions can form intramolecularly as well as intermolecularly. Intermolecular quadruplexes can be arranged from two strands (each containing two GGG stretches) or four strands (one GGG stretch each). The spacing (loops) between the GGG stretches can vary between 1 and 7 nucleotides ([@gks1448-B37]).

*In silico* studies have shown that putative Quadruplex structures (pQS) are abundant in prokaryotic as well as eukaryotic gene promoters and G-rich telomeres found at the end of chromosomes ([@gks1448-B38]). The presence of QS in human gene promoters has been shown to result in transcriptional repression ([@gks1448-B39]). When QS are present in the 5′ untranslated region of the mRNA, it can interfere with ribosome binding and translation initiation ([@gks1448-B42],[@gks1448-B43]).

When we analyzed the whole *C. difficile* (strain 630) genome in Quadfinder, an online server for prediction of quadruplex-forming motifs in nucleotide sequences ([@gks1448-B37]), we found five pQS. Unfortunately, none of these were located in the PaLoc, where TcdC is speculated to act. Three pQS are present within open reading frames (CD1092A, CD1115 and CD1849) and two in the 3′untranslated region of genes (CD0938 and CD2929) in the strand that is complementary to mRNA (producing CCC stretches in the mRNA). It should be noted that prediction programs can only identify intramolecular QS (four GGG stretches on the same strand), not the bimolecular or tetramolecular forms.

Telomers contain ss repeats of TAGGG found at the end of chromosomes, protecting them from exonuclease degradation. Intramolecular QS of these TAGGG repeats play a role in telomere maintenance ([@gks1448-B44]). However, to efficiently replicate the lagging strand of these telomeres, these QS must be disrupted, thereby permitting processive telomere elongation. At least two proteins have been reported to bind and unfold these QSs, human POT1 and RPA, both characterized by the presence of an OB-fold ([@gks1448-B45]). Despite the similarity in protein fold and DNA recognition site between TcdC (aGGG) and these OB-fold proteins (TAGGG), we could not find identical DNA contacting aa when the TcdC structure was superimposed on the hPOT-1-DNA co-crystal ([@gks1448-B44]). Although the circular genomes of Firmicutes do not contain ss ends, a role for the OB-fold containing TcdC homologues in destabilizing alternative DNA secondary structures could be envisaged.

An *alternative* mechanism of TcdC action might be exemplified by the eukaryotic RNA polymerase II complex, which includes a subunit (rpb7) with an OB-fold. It was speculated that this OB-fold domain, which is located at the RNA exit path, binds RNA as it exits the enzyme, thereby stabilizing the early transcribing complex ([@gks1448-B49]). An opposite effect, i.e. destabilizing the initiation complex by an OB-fold protein, such as TcdC, could be pictured. An unexpected G-QS is described in the crystal structure of a bacterial −10 promoter element, 5′ TGTACAATGGG 3′ (−14 to −4), complexed with sigma factor Taqσ^A^ ([@gks1448-B50]). In this structure, the downstream G~−6~G~−5~G~−4~ do not interact with the protein but twist away from the protein--DNA complex and form G-quadruplexes with other (symmetry-related) GGG motifs. The relevance in this complex was not clear and such a GGG-motif is absent next to the *tcdA* −10 promoter element.

*TcdC* is part of the PaLoc, a well-defined genetic element that is present at identical locations in the chromosome of pathogenic *C. difficile* strains. In non-toxinogenic strains, however, it is completely absent. These observations have led to the suggestion that the PaLoc may be associated with a (bacteriophage) transposable genetic element ([@gks1448-B51]). Examining the genomic location of TcdC homologues of other Firmicutes showed that several of these family members are located on insertional elements. For example, the TcdC homologue (E-value 1e-23) of *Oenococuss oeni* strain PSU-1 (see [Supplementary Figure S5](http://nar.oxfordjournals.org/lookup/suppl/doi:10.1093/nar/gks1448/-/DC1)) is part of an insertion containing four additional genes encoding three putative cell-wall proteins and one site-specific recombinase. In contrast, a TcdC homologue of *Bacillus cereus* strain 172560 (E-value 1e-41) is inserted without any additional genes.

It is interesting to mention that the TcdC variants present in Lactobacillus and Leuconostoc are also found in their homologous phages (i.e. Lactobacillus phages A2 and Lrm1 and Leuconostoc phage phiMH1). In these phages, the TcdC homologues are present in the lysis/lysogeny genetic switch operon, located between the CI repressor and Int, integrase, suggesting that TcdC is part of the regulatory decision circuit.

Our overall data suggest that *C. difficile* TcdC forms an OB-fold that binds QSs. However, the *in vivo* relevance remains unreported. Extensive investigations showed no binding to *tcdA* promoter elements. Clearly, QSs play a role in gene regulation and expression. Unfortunately, no multiple G-stretches are found within the PaLoc where TcdC is thought to exert its function. It may well be that the ss regions of the quadruplex mimics another structure bound by TcdC and the quadruplex is an approximation of the optimal structural binding determinant. It remains to be established in which way the capability of dimeric TcdC to bind G-quadruplexes demonstrated in this study relates to its role as a transcriptional repressor or another cellular function.
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[^1]: Oligonucleotides sequences obtained are aligned. Stretches of 3G or longer and corresponding to the consensus are highlighted in bold. Underlined are the constant sequences flanking the randomized 15 nucleotides.
